What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2)SARS-CoV-2 감염 후 자연 면역을 부여하는 항체 반응과 역할은 무엇입니까? American College of Physicians(버전 2)의 신속하고 생생한 실습 포인트Article Published on 2022-04-012022-09-11 Journal: Annals of internal medicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] agency antibody Antibody Response antibody tests best cellular immunity college Committee conducted diagnosis of SARS-CoV-2 effective vaccine Effective vaccines evaluate Evidence foundation Immunity Infection natural natural immunity physician Point Policy Practice predict Prevalence preventing infection Quality Rapid recommendation Reinfection response retirement role SARS-CoV-2 SARS-CoV-2 antibody test SARS-CoV-2 antibody tests SARS-COV-2 infection systematic review the antibody response Topic vaccination variants Version widespread [DOI] 10.7326/M21-3272 PMC 바로가기 [Article Type] Article
Ozone gas applied through nebulization as adjuvant treatment for lung respiratory diseases due to COVID-19 infections: a prospective randomized trialRandomized Controlled Trial Published on 2022-04-012022-10-04 Journal: Medical gas research [Category] COVID19(2023년), SARS, 임상, [키워드] applied approval approved C-reactive protein clinical clinical symptom Committee Computed tomography control group coronavirus coronavirus disease COVID-19 COVID-19 patient criteria D-dimer evaluated faster group hospital İstanbul lactate dehydrogenase leukocyte lung lung disinfection lymphocyte medical ozone gas ozone gas ozone inhalation Ozone therapy Patient patients Platelet Pneumonia polymerase chain pulmonary disease randomized trial reduce Respiratory disease respond statistically significant difference the patient treated Treatment two groups university urea Viral load viral puenmonia. [DOI] 10.4103/2045-9912.326001 PMC 바로가기 [Article Type] Randomized Controlled Trial
Pharmacological treatment of COVID-19: an opinion paperCOVID-19의 약리학적 치료: 의견서Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 치료제, [키워드] adalimumab Anakinra approach AZD7442 Azithromycin Banlanivimab Baricitinib BRII-196 BRII-198 canakinumab Casirivimab Certolizumab Ciganilmab Colchicine college Committee convalescent convalescent plasma COVID-19 Critical Dexamethasone drug drugs effective Efficacy English Etanercept etesevimab Evusheld Favipiravir fluvoxamine Golimumab help Hydroxychloroquine Imdevinab immune response Immunotherapy indication infliximab itolizumab Ivermectin Lemilumab Lopinavir Lopinavir/ritonavir Medicines metformin molnupiravir offer Pandemia pandemic Paxlovid PF-07321332 physician precocity prevented Ravulizumab Remdesivir Ritonavir ruxolitinib sarilumab SARS-CoV-2 Scientific Committee Sotrovimab Spanish the vaccine therapeutic Tixagevimab Tocilizumab Tofacitinib Treatment Vaccine virus Vitamin Vitamin D [DOI] 10.37201/req/158.2021 PMC 바로가기 [Article Type] Review
Booster or additional vaccination doses in patients vaccinated against COVID-19COVID-19 예방 접종을 받은 환자의 추가 접종 또는 추가 접종Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 변종, [키워드] accelerate additional doses administer Administered administration adverse effect asked booster booster dose college Committee Consensus COVID COVID-19 COVID-19 vaccine criteria decrease deliberation dose doubt Efficacy English form group Health Health Organization higher risk immunocompromised individual immunocompromised individuals incompatible individual information Laboratory tests lack less lower risk moment mRNA mRNA vaccines observation period organizations Patient physician Population population groups question reduce risk SARS-CoV-2 Spanish spur the disease the vaccine third dose vaccinated against COVID-19 vaccination Vaccines variant virus World Health Organization [DOI] 10.37201/req/149.2021 PMC 바로가기 [Article Type] Review
COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemicCOVID-19 중재 시험: 팬데믹 기간 동안 데이터 공유 의도 분석Article Published on 2022-04-012022-09-11 Journal: Contemporary clinical trials [Category] 임상, [키워드] accelerate actual changed Clinical studies clinical study ClinicalTrials.gov Committee COVID-19 Data sharing dataset evaluated expand Follow-up ICMJE inclusion criteria information initial Intention IPD. journal pandemic positive reflected Registered Registration remained Research subset Trial Volunteer [DOI] 10.1016/j.cct.2022.106709 PMC 바로가기 [Article Type] Article
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine중국 최초의 단백질 소단위 SARS-CoV-2 백신 국가표준 제정Article Published on 2022-03-252022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] accelerated addition Antigen Antigen content approved asked assigned Biological Biological product calibration China Chinese Committee contribute Control COVID-19 Degradation detect determined by drug ELISA enzyme-linked immunosorbent enzyme-linked immunosorbent assay exhibited expression food house Laboratory linear relationship National national standard potency produced product Protein subunit Quality control reference material reference standard Reference standards returned SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines stability target proteins Vaccine was performed [DOI] 10.1016/j.vaccine.2022.02.048 PMC 바로가기 [Article Type] Article
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years – PROTECT Cohort, July 2021-February 20225-11세 아동 및 12-15세 청소년 사이에서 SARS-CoV-2 감염 예방에 2회분 BNT162b2(Pfizer BioNTech) mRNA 백신의 효과 - PROTECT 코호트, 2021년 7월-2022년 2월Article Published on 2022-03-182022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] 95% CI adjusted Adolescent age average B.1.1.529 B.1.617.2 BNT162b2 CDC children circulation Committee COVID-19 symptom COVID-19 symptoms COVID-19 vaccinations COVID-19 vaccine Delta demonstrated dose doses Effectiveness eligible Frequency group health information Infection laboratory-confirmed SARS-CoV-2 infection less Local location mRNA omicron participant Pfizer Pfizer-BioNTech Practice predominant Preventing prospective cohort real-world data receipt referred to SARS-CoV-2 SARS-COV-2 infection sick social contact Sociodemographic characteristics symptomatic and asymptomatic symptomatic infection Symptoms the United State United States Vaccine variant virus was tested Year [DOI] 10.15585/mmwr.mm7111e1 PMC 바로가기 [Article Type] Article
Intracranial otogenic complications in adults: new factors that influenced its onset, frequency and natureOriginal Research Article Published on 2022-03-042022-10-29 Journal: Journal of Otolaryngology - Head & Neck Surgery [Category] COVID-19, MERS, SARS, [키워드] Abstract Analysis approval bioethics Brain Cerebral venous thrombosis clinical feature Cohort Committee Complication complications concerning conducted COVID COVID-19 COVID-19 cohort COVID-19 pandemic expected Factor Frequency incidence Infection Intracranial Latent otitis media Medical Science Medical Sciences Meningitis otitis media Otogenic complication outcome outpatient consultation Patient presenting prevalent proportion reported Research Result SARS-CoV-2 Sigmoid sinus thrombosis surgical thrombosis university with COVID-19 [DOI] 10.1186/s40463-021-00554-6 PMC 바로가기 [Article Type] Original Research Article
Older patients’ perspectives on illness and healthcare during the early phase of the COVID-19 pandemicEmpirical Paper Published on 2022-03-032022-10-31 Journal: Nursing Ethics [Category] COVID-19, MERS, [키워드] access to healthcare age approach assessment Care Committee competent conducted COVID-19 COVID-19 pandemic criteria dependent on described discharge disease early phase Equal Ethical approval ethical standard Ethics finding Health Health services healthcare Healthcare system hospital hospitalisation hospitalised knowledge National Norway Nurses Older older people pandemic participant performed Perspective priorities receive recruited Regional Research Research design severe disease supported Symptom tested vulnerability [DOI] 10.1177/09697330211072362 PMC 바로가기 [Article Type] Empirical Paper
WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific communityPersonal View Published on 2022-03-012022-10-31 Journal: The Lancet. Microbe [Category] COVID-19, MERS, SARS, [키워드] anti-SARS-CoV-2 Biological calibrated calibration Committee conducted contribute COVID-19 COVID-19 vaccines diagnostic expected expert facilitate immune response Immunoglobulin National neutralising antibody Panel provide public health reagents reference SARS-CoV-2 Scientific community Standard the antibody response the WHO therapeutic View WHO [DOI] 10.1016/S2666-5247(21)00266-4 PMC 바로가기 [Article Type] Personal View